High grade B-cell lymphoma with MYC and BCL2 rearrangements (HGBCL-DH) represents an uncommon B-cell lymphoma (BCL) with aggressive clinical courses and poor prognosis. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.